A recent survey showed that compared to transplant patients with the wild-type gene, those with a TLR9 gene variant at position 1486C had desirable outcomes, which was attributed to decreased transplant-associated mortality associated with GVHD [27]. This evidence concerns the gene TLR9 and graft versus host disease.